{"transactions":[{"id":863764,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-03-04T23:51:03.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":2149,"price":37.7756,"value":81179.7644,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":60097,"source":{"system":"sec-edgar","filing":"0001628280-26-014894","document":"wk-form4_1772668260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026014894/wk-form4_1772668260.xml","form_type":"4"}},{"id":863763,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-03-04T23:51:03.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":21838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date."}],"balance_after":62246,"source":{"system":"sec-edgar","filing":"0001628280-26-014894","document":"wk-form4_1772668260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026014894/wk-form4_1772668260.xml","form_type":"4"}},{"id":871811,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-03-03T20:04:30.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1513,"price":38.0249,"value":57531.6737,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":40408,"source":{"system":"sec-edgar","filing":"0001628280-26-013690","document":"wk-form4_1772568267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026013690/wk-form4_1772568267.xml","form_type":"4"}},{"id":883115,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-02-25T22:36:26.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":1259,"price":35.693,"value":44937.487,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":41921,"source":{"system":"sec-edgar","filing":"0001628280-26-011837","document":"wk-form4_1772058983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026011837/wk-form4_1772058983.xml","form_type":"4"}},{"id":883114,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-02-25T22:36:26.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":2423,"price":37.588,"value":91075.724,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":43180,"source":{"system":"sec-edgar","filing":"0001628280-26-011837","document":"wk-form4_1772058983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026011837/wk-form4_1772058983.xml","form_type":"4"}},{"id":929435,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-01-28T20:53:37.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":316,"price":26.138,"value":8259.608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3."}],"balance_after":45603,"source":{"system":"sec-edgar","filing":"0001628280-26-003824","document":"wk-form5_1769633614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026003824/wk-form5_1769633614.xml","form_type":"5"}},{"id":929434,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2026-01-28T20:53:37.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":534,"price":24.302,"value":12977.268,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3."}],"balance_after":45287,"source":{"system":"sec-edgar","filing":"0001628280-26-003824","document":"wk-form5_1769633614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026003824/wk-form5_1769633614.xml","form_type":"5"}},{"id":990736,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":27075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023."}],"balance_after":0,"derivative":{"exercise_price":11.03,"exercise_date":"2023-11-08","expiration_date":"2029-11-08","underlying":"Common Stock","underlying_shares":27075},"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990735,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":20301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023."}],"balance_after":0,"derivative":{"exercise_price":18.44,"exercise_date":"2023-02-23","expiration_date":"2029-02-23","underlying":"Common Stock","underlying_shares":20301},"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990734,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":8370,"price":45.345,"value":379537.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects weighted average price. Range of prices were between $45.26 to $45.53. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer,\nfull information regarding the number of shares sold at each separate price."}],"balance_after":44753,"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990733,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":18705,"price":44.91,"value":840041.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects weighted average price. Range of prices were between $44.26 to $45.255. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer,\nfull information regarding the number of shares sold at each separate price."}],"balance_after":53123,"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990732,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":27075,"price":11.03,"value":298637.25,"ownership":{"direct":true},"balance_after":71828,"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990731,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":5715,"price":45.346,"value":259152.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects weighted average price. Range of prices were between $45.26 to $45.54. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer,\nfull information regarding the number of shares sold at each separate price."}],"balance_after":44753,"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990730,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":14586,"price":44.919,"value":655188.534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects weighted average price. Range of prices were between $44.26 to $45.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer,\nfull information regarding the number of shares sold at each separate price."}],"balance_after":50468,"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990729,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T22:23:45.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":20301,"price":18.44,"value":374350.44,"ownership":{"direct":true},"balance_after":65054,"source":{"system":"sec-edgar","filing":"0001628280-25-053859","document":"wk-form4_1764023022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053859/wk-form4_1764023022.xml","form_type":"4"}},{"id":990728,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":1355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023."}],"balance_after":27075,"derivative":{"exercise_price":11.03,"exercise_date":"2023-11-08","expiration_date":"2029-11-08","underlying":"Common Stock","underlying_shares":1355},"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":990727,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":2033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023."}],"balance_after":20301,"derivative":{"exercise_price":18.44,"exercise_date":"2023-02-23","expiration_date":"2029-02-23","underlying":"Common Stock","underlying_shares":2033},"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":990726,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":1355,"price":44.278,"value":59996.69,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects weighted average price. Range of prices were between $44.26 to $44.35. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44753,"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":990725,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":1355,"price":11.03,"value":14945.65,"ownership":{"direct":true},"balance_after":46108,"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":990724,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":2033,"price":44.315,"value":90092.395,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects weighted average price. Range of prices were between $44.26 to $44.44. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44753,"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":990723,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":2033,"price":18.44,"value":37488.52,"ownership":{"direct":true},"balance_after":46786,"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":990722,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-24T14:35:59.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":11888,"price":44.14,"value":524736.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects weighted average price. Range of prices were between $43.92 to $44.49. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44753,"source":{"system":"sec-edgar","filing":"0001628280-25-053702","document":"wk-form4_1763994956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025053702/wk-form4_1763994956.xml","form_type":"4"}},{"id":999465,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-14T17:07:29.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":4993,"price":45.858,"value":228968.994,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations.  The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":56641,"source":{"system":"sec-edgar","filing":"0001628280-25-052260","document":"wk-form4_1763140046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025052260/wk-form4_1763140046.xml","form_type":"4"}},{"id":1003128,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-11-13T01:05:44.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":2566,"price":44.619,"value":114492.354,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations.  The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":61634,"source":{"system":"sec-edgar","filing":"0001628280-25-051789","document":"wk-form4_1762995941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828025051789/wk-form4_1762995941.xml","form_type":"4"}},{"id":1054178,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T22:08:42.000Z","date":"2025-08-27","kind":"exercise","planned":false,"acquired":false,"shares":18200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023."}],"balance_after":0,"derivative":{"exercise_price":11.03,"exercise_date":"2023-11-08","expiration_date":"2029-11-08","underlying":"Common Stock","underlying_shares":18200},"source":{"system":"sec-edgar","filing":"0001849615-25-000003","document":"wk-form4_1756418919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000184961525000003/wk-form4_1756418919.xml","form_type":"4"}},{"id":1054177,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-08-28T22:08:42.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":18200,"price":44.023,"value":801218.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":64200,"source":{"system":"sec-edgar","filing":"0001849615-25-000003","document":"wk-form4_1756418919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000184961525000003/wk-form4_1756418919.xml","form_type":"4"}},{"id":1054176,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-08-28T22:08:42.000Z","date":"2025-08-27","kind":"exercise","planned":false,"acquired":true,"shares":18200,"price":11.03,"value":200746.0,"ownership":{"direct":true},"balance_after":82400,"source":{"system":"sec-edgar","filing":"0001849615-25-000003","document":"wk-form4_1756418919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000184961525000003/wk-form4_1756418919.xml","form_type":"4"}},{"id":1106997,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-06-18T15:48:26.000Z","date":"2025-06-17","kind":"sale","planned":true,"acquired":false,"shares":1236,"price":29.5,"value":36462.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the price the shares were sold."}],"balance_after":64200,"source":{"system":"sec-edgar","filing":"0000784199-25-000133","document":"wk-form4_1750261700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000133/wk-form4_1750261700.xml","form_type":"4"}},{"id":1106996,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-06-18T15:48:26.000Z","date":"2025-06-17","kind":"sale","planned":true,"acquired":false,"shares":13764,"price":29.5,"value":406038.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the price the shares were sold."}],"balance_after":65436,"source":{"system":"sec-edgar","filing":"0000784199-25-000133","document":"wk-form4_1750261700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000133/wk-form4_1750261700.xml","form_type":"4"}},{"id":1110543,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-06-17T00:22:21.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":1826,"price":28.4277,"value":51908.9802,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":79200,"source":{"system":"sec-edgar","filing":"0000784199-25-000131","document":"wk-form4_1750119734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000131/wk-form4_1750119734.xml","form_type":"4"}},{"id":1110542,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-06-17T00:22:21.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":14306,"price":28.4217,"value":406600.8402,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects weighted average price for Performance Stock Units. Range of prices were between $28.17 to $28.675. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":81026,"source":{"system":"sec-edgar","filing":"0000784199-25-000131","document":"wk-form4_1750119734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000131/wk-form4_1750119734.xml","form_type":"4"}},{"id":1110541,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-06-17T00:22:21.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":1253,"price":28.4666,"value":35668.6498,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":95332,"source":{"system":"sec-edgar","filing":"0000784199-25-000131","document":"wk-form4_1750119734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000131/wk-form4_1750119734.xml","form_type":"4"}},{"id":1110540,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-06-17T00:22:21.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":8747,"price":28.4615,"value":248952.7405,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects weighted average price for Performance Stock Units. Range of prices were between $28.175 to $28.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96585,"source":{"system":"sec-edgar","filing":"0000784199-25-000131","document":"wk-form4_1750119734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000131/wk-form4_1750119734.xml","form_type":"4"}},{"id":1153024,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-05-12T18:31:31.000Z","date":"2025-05-09","kind":"sale","planned":false,"acquired":false,"shares":4811,"price":29.1302,"value":140145.3922,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects weighted average price for Performance Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":105332,"source":{"system":"sec-edgar","filing":"0000784199-25-000076","document":"wk-form4_1747074683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000076/wk-form4_1747074683.xml","form_type":"4"}},{"id":1153023,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-05-12T18:31:31.000Z","date":"2025-05-09","kind":"sale","planned":false,"acquired":false,"shares":5737,"price":29.1302,"value":167119.9574,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects weighted average price for Restricted Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":110143,"source":{"system":"sec-edgar","filing":"0000784199-25-000076","document":"wk-form4_1747074683.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000076/wk-form4_1747074683.xml","form_type":"4"}},{"id":1216463,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-03-10T21:03:12.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":1603,"price":24.8042,"value":39761.1326,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":115880,"source":{"system":"sec-edgar","filing":"0000784199-25-000049","document":"wk-form4_1741640586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000049/wk-form4_1741640586.xml","form_type":"4"}},{"id":1216462,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-03-10T21:03:12.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":19240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date."}],"balance_after":117483,"source":{"system":"sec-edgar","filing":"0000784199-25-000049","document":"wk-form4_1741640586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000049/wk-form4_1741640586.xml","form_type":"4"}},{"id":1233174,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-03-04T20:08:14.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":18398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan."}],"balance_after":98243,"source":{"system":"sec-edgar","filing":"0000784199-25-000041","document":"wk-form4_1741118887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000041/wk-form4_1741118887.xml","form_type":"4"}},{"id":1244507,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-02-26T18:46:21.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":1246,"price":27.306,"value":34023.276,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":79845,"source":{"system":"sec-edgar","filing":"0000784199-25-000014","document":"wk-form4_1740595575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000014/wk-form4_1740595575.xml","form_type":"4"}},{"id":1244506,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-02-26T18:46:21.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":672,"price":27.306,"value":18349.632,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":81091,"source":{"system":"sec-edgar","filing":"0000784199-25-000014","document":"wk-form4_1740595575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000014/wk-form4_1740595575.xml","form_type":"4"}},{"id":1244505,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-02-26T18:46:21.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":470,"price":27.306,"value":12833.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":81763,"source":{"system":"sec-edgar","filing":"0000784199-25-000014","document":"wk-form4_1740595575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000014/wk-form4_1740595575.xml","form_type":"4"}},{"id":1244504,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-02-26T18:46:21.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":2299,"price":27.306,"value":62776.494,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":82233,"source":{"system":"sec-edgar","filing":"0000784199-25-000014","document":"wk-form4_1740595575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000014/wk-form4_1740595575.xml","form_type":"4"}},{"id":1291333,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-01-30T15:13:17.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":381,"price":21.63,"value":8241.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3."}],"balance_after":84532,"source":{"system":"sec-edgar","filing":"0000784199-25-000004","document":"wk-form5_1738249991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000004/wk-form5_1738249991.xml","form_type":"5"}},{"id":1291332,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2025-01-30T15:13:17.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":855,"price":15.2,"value":12996.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3."}],"balance_after":84151,"source":{"system":"sec-edgar","filing":"0000784199-25-000004","document":"wk-form5_1738249991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000004/wk-form5_1738249991.xml","form_type":"5"}},{"id":1565443,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-21T21:14:07.000Z","date":"2024-03-20","kind":"sale","planned":false,"acquired":false,"shares":2183,"price":20.39,"value":44511.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":83296,"source":{"system":"sec-edgar","filing":"0000784199-24-000164","document":"wk-form4_1711055634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000164/wk-form4_1711055634.xml","form_type":"4"}},{"id":1577672,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:36:32.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":1431,"price":20.2711,"value":29007.9441,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,448 shares were sold, when in fact, 1,431 shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4."}],"balance_after":81726,"source":{"system":"sec-edgar","filing":"0000784199-24-000154","document":"wk-form4a_1710462983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000154/wk-form4a_1710462983.xml","form_type":"4/A","original_submission_date":"2024-02-28"}},{"id":1577671,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:36:32.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":10644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4."}],"balance_after":83157,"source":{"system":"sec-edgar","filing":"0000784199-24-000154","document":"wk-form4a_1710462983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000154/wk-form4a_1710462983.xml","form_type":"4/A","original_submission_date":"2024-02-28"}},{"id":1577670,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:36:32.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":1576,"price":20.2711,"value":31947.2536,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,600 shares were sold, when in fact, 1,576 shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4."}],"balance_after":72513,"source":{"system":"sec-edgar","filing":"0000784199-24-000154","document":"wk-form4a_1710462983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000154/wk-form4a_1710462983.xml","form_type":"4/A","original_submission_date":"2024-02-28"}},{"id":1577669,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:36:32.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":5386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024."}],"balance_after":74089,"source":{"system":"sec-edgar","filing":"0000784199-24-000154","document":"wk-form4a_1710462983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000154/wk-form4a_1710462983.xml","form_type":"4/A","original_submission_date":"2024-02-28"}},{"id":1577652,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:25:36.000Z","date":"2024-02-27","kind":"sale","planned":false,"acquired":false,"shares":465,"price":19.8344,"value":9222.996,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4."}],"balance_after":81261,"source":{"system":"sec-edgar","filing":"0000784199-24-000144","document":"wk-form4a_1710462326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000144/wk-form4a_1710462326.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1577640,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:06:56.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":1506,"price":18.7221,"value":28195.4826,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4."}],"balance_after":85479,"source":{"system":"sec-edgar","filing":"0000784199-24-000128","document":"wk-form4a_1710461203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000128/wk-form4a_1710461203.xml","form_type":"4/A","original_submission_date":"2024-03-07"}},{"id":1577639,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-15T00:06:56.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents LTIP performance stock units of which one hundred percent (100%) were issued on March 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4."}],"balance_after":86985,"source":{"system":"sec-edgar","filing":"0000784199-24-000128","document":"wk-form4a_1710461203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000128/wk-form4a_1710461203.xml","form_type":"4/A","original_submission_date":"2024-03-07"}},{"id":1590258,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-07T23:05:14.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":1506,"price":18.7221,"value":28195.4826,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":85438,"source":{"system":"sec-edgar","filing":"0000784199-24-000096","document":"wk-form4_1709852706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000096/wk-form4_1709852706.xml","form_type":"4"}},{"id":1590257,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-03-07T23:05:14.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents LTIP performance stock units of which one hundred percent (100%) were issued on March 1, 2024."}],"balance_after":86944,"source":{"system":"sec-edgar","filing":"0000784199-24-000096","document":"wk-form4_1709852706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000096/wk-form4_1709852706.xml","form_type":"4"}},{"id":1611180,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-02-29T22:18:32.000Z","date":"2024-02-27","kind":"sale","planned":false,"acquired":false,"shares":465,"price":19.8344,"value":9222.996,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":81220,"source":{"system":"sec-edgar","filing":"0000784199-24-000076","document":"wk-form4_1709245096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000076/wk-form4_1709245096.xml","form_type":"4"}},{"id":1613687,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-02-28T22:01:34.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":1448,"price":20.2711,"value":29352.5528,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":81685,"source":{"system":"sec-edgar","filing":"0000784199-24-000059","document":"wk-form4_1709157669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000059/wk-form4_1709157669.xml","form_type":"4"}},{"id":1613686,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-02-28T22:01:34.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":10644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date"}],"balance_after":83133,"source":{"system":"sec-edgar","filing":"0000784199-24-000059","document":"wk-form4_1709157669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000059/wk-form4_1709157669.xml","form_type":"4"}},{"id":1613685,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-02-28T22:01:34.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":20.2711,"value":32433.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":72489,"source":{"system":"sec-edgar","filing":"0000784199-24-000059","document":"wk-form4_1709157669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000059/wk-form4_1709157669.xml","form_type":"4"}},{"id":1613684,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-02-28T22:01:34.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":5386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024."}],"balance_after":74089,"source":{"system":"sec-edgar","filing":"0000784199-24-000059","document":"wk-form4_1709157669.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000059/wk-form4_1709157669.xml","form_type":"4"}},{"id":1621024,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-02-26T22:50:04.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":14800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan."}],"balance_after":68703,"source":{"system":"sec-edgar","filing":"0000784199-24-000039","document":"wk-form4_1708987779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000039/wk-form4_1708987779.xml","form_type":"4"}},{"id":1667236,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-01-31T01:00:59.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":565,"price":14.6115,"value":8255.4975,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3."}],"balance_after":53903,"source":{"system":"sec-edgar","filing":"0000784199-24-000006","document":"wk-form5_1706662850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000006/wk-form5_1706662850.xml","form_type":"5"}},{"id":1667235,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2024-01-31T01:00:59.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1261,"price":10.302,"value":12990.822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3."}],"balance_after":53338,"source":{"system":"sec-edgar","filing":"0000784199-24-000006","document":"wk-form5_1706662850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000006/wk-form5_1706662850.xml","form_type":"5"}},{"id":1977078,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-03-03T22:56:32.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":907,"price":13.4118,"value":12164.5026,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":52077,"source":{"system":"sec-edgar","filing":"0000784199-23-000066","document":"wf-form4_167788416682175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000066/wf-form4_167788416682175.xml","form_type":"4"}},{"id":1977077,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-03-03T22:56:32.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":3663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents LTIP performance stock units of which hundred percent (100%) were issued on March 1, 2023."}],"balance_after":52984,"source":{"system":"sec-edgar","filing":"0000784199-23-000066","document":"wf-form4_167788416682175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000066/wf-form4_167788416682175.xml","form_type":"4"}},{"id":1985196,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-03-01T23:27:09.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":1161,"price":12.938,"value":15021.018,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":49321,"source":{"system":"sec-edgar","filing":"0000784199-23-000044","document":"wf-form4_167771320949974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000044/wf-form4_167771320949974.xml","form_type":"4"}},{"id":1985195,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-03-01T23:27:09.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":7440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date."}],"balance_after":50482,"source":{"system":"sec-edgar","filing":"0000784199-23-000044","document":"wf-form4_167771320949974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000044/wf-form4_167771320949974.xml","form_type":"4"}},{"id":1985194,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-03-01T23:27:09.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":1176,"price":12.938,"value":15215.088,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":43042,"source":{"system":"sec-edgar","filing":"0000784199-23-000044","document":"wf-form4_167771320949974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000044/wf-form4_167771320949974.xml","form_type":"4"}},{"id":1985193,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-03-01T23:27:09.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":3770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023."}],"balance_after":44218,"source":{"system":"sec-edgar","filing":"0000784199-23-000044","document":"wf-form4_167771320949974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000044/wf-form4_167771320949974.xml","form_type":"4"}},{"id":2044355,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-01-27T22:24:18.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":443,"price":10.302,"value":4563.786,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3"}],"balance_after":40448,"source":{"system":"sec-edgar","filing":"0000784199-23-000008","document":"wf-form5_167485824303268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000008/wf-form5_167485824303268.xml","form_type":"5"}},{"id":2044354,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2023-01-27T22:24:18.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":810,"price":16.048,"value":12998.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3"}],"balance_after":40005,"source":{"system":"sec-edgar","filing":"0000784199-23-000008","document":"wf-form5_167485824303268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000008/wf-form5_167485824303268.xml","form_type":"5"}},{"id":2120577,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2022-11-10T14:29:54.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":46630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date"}],"balance_after":46630,"derivative":{"exercise_price":11.03,"exercise_date":"2023-11-08","expiration_date":"2029-11-08","underlying":"Common Stock","underlying_shares":46630},"source":{"system":"sec-edgar","filing":"0000784199-22-000213","document":"wf-form4_166809057926995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419922000213/wf-form4_166809057926995.xml","form_type":"4"}},{"id":2120576,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2022-11-10T14:29:54.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":19447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company."}],"balance_after":39195,"source":{"system":"sec-edgar","filing":"0000784199-22-000213","document":"wf-form4_166809057926995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419922000213/wf-form4_166809057926995.xml","form_type":"4"}},{"id":2376397,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2022-02-24T21:36:19.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":22334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date."}],"balance_after":22334,"derivative":{"exercise_price":18.44,"exercise_date":"2023-02-23","expiration_date":"2029-02-23","underlying":"Common Stock","underlying_shares":22334},"source":{"system":"sec-edgar","filing":"0000784199-22-000098","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419922000098/certent-form4.xml","form_type":"4"}},{"id":2376396,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2022-02-24T21:36:19.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":8406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company."}],"balance_after":19748,"source":{"system":"sec-edgar","filing":"0000784199-22-000098","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419922000098/certent-form4.xml","form_type":"4"}},{"id":2383797,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2022-02-22T12:33:40.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":772,"price":17.5,"value":13510.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations."}],"balance_after":11342,"source":{"system":"sec-edgar","filing":"0000784199-22-000056","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419922000056/certent-form4.xml","form_type":"4"}},{"id":2383796,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2022-02-22T12:33:40.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":2603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on Feb 17, 2021. Hundred percent (100%) were issued on Feb 17, 2022."}],"balance_after":12114,"source":{"system":"sec-edgar","filing":"0000784199-22-000056","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419922000056/certent-form4.xml","form_type":"4"}},{"id":2780376,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":63013,"kind":"person","name":"Stanton Marshall S.","position":1,"cik":"0001849615","reported_name":"Stanton Marshall S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical & MD Affair"}}],"security":"Common Stock","published_at":"2021-03-18T12:50:58.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":8511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company."}],"balance_after":9511,"source":{"system":"sec-edgar","filing":"0000784199-21-000103","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419921000103/certent-form4.xml","form_type":"4"}}]}